<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2026-04-03-04:00" xsi:noNamespaceSchemaLocation="https://www.reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>0910-AI50</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>202304</PUBLICATION_ID>
            <PUBLICATION_TITLE>Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>0910</CODE>
            <NAME>Food and Drug Administration</NAME>
            <ACRONYM>FDA</ACRONYM>
        </AGENCY>
        <PARENT_AGENCY>
            <CODE>0900</CODE>
            <NAME>Department of Health and Human Services</NAME>
            <ACRONYM>HHS</ACRONYM>
        </PARENT_AGENCY>
        <RULE_TITLE>Amending Regulations That Require Multiple Copies Submissions </RULE_TITLE>
        <ABSTRACT><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>This proposed rule would amend FDA&rsquo;s regulations to remove requirements for submission of multiple copies and replace them with the requirement for a single submission in electronic format. This action is being undertaken to revise regulations that required paper submission in duplicate, triplicate, etc.</p>
</body>
</html>]]></ABSTRACT>
        <PRIORITY_CATEGORY>Substantive, Nonsignificant</PRIORITY_CATEGORY>
        <RIN_STATUS>Previously Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Proposed Rule Stage</RULE_STAGE>
        <MAJOR>No</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <CFR_LIST>
            <CFR>21 CFR 101.69</CFR>
            <CFR>21 CFR 130.17</CFR>
            <CFR>21 CFR 171.1</CFR>
            <CFR>21 CFR 571.1</CFR>
            <CFR>21 CFR 71.1</CFR>
            <CFR>21 CFR 10.20</CFR>
            <CFR>21 CFR 10.40</CFR>
            <CFR>21 CFR 10.85</CFR>
            <CFR>21 CFR 314.94</CFR>
            <CFR>21 CFR 314.50</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>5 U.S.C. 551 to 558</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>5 U.S.C. 701 to 706</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>15 U.S.C. 1453</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>15 U.S.C. 1454</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>15 U.S.C. 1455</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 141 to 149</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 321</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 331</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 336</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 341</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 342</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 343</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 348</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 351</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 352</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 353</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 355</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 360</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 360c</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 360j</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 360l</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 360aa</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 360aaa-6</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 360b-360f</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 360bbb-8b</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 360h to 360i</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 361</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 371</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 372</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 373</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 374</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 375</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 379</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 379e</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 379k-1</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 381</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 467f</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 679</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 821</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>21 U.S.C. 1034</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>28 U.S.C. 2112</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 U.S.C. 201</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 U.S.C. 216</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 U.S.C. 241</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 U.S.C. 243</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 U.S.C. 262</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 U.S.C. 263b</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 U.S.C. 264</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 U.S.C. 271</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>...</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST>
            <LEGAL_DLINE_INFO>
                <DLINE_TYPE>Statutory</DLINE_TYPE>
                <DLINE_ACTION_STAGE>NPRM</DLINE_ACTION_STAGE>
                <DLINE_DATE>09/30/2022</DLINE_DATE>
                <DLINE_DESC></DLINE_DESC>
            </LEGAL_DLINE_INFO>
        </LEGAL_DLINE_LIST>
        <RPLAN_ENTRY>No</RPLAN_ENTRY>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>NPRM</TTBL_ACTION>
                <TTBL_DATE>10/00/2023</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <RFA_REQUIRED>No</RFA_REQUIRED>
        <SMALL_ENTITY_LIST>
            <SMALL_ENTITY>No</SMALL_ENTITY>
        </SMALL_ENTITY_LIST>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>None</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <FEDERALISM>No</FEDERALISM>
        <PRINT_PAPER>No</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>No</INTERNATIONAL_INTEREST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Shena</FIRST_NAME>
                <LAST_NAME>Arellano</LAST_NAME>
                <TITLE>Policy Analyst</TITLE>
                <AGENCY>
                    <CODE>0910</CODE>
                    <NAME>Food and Drug Administration</NAME>
                    <ACRONYM>FDA</ACRONYM>
                </AGENCY>
                <PHONE>301 796-8353</PHONE>
                <EMAIL>shena.arellano@fda.hhs.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>Office of the Commissioner, 10903 New Hampshire Avenue,</STREET_ADDRESS>
                    <CITY>Silver Spring</CITY>
                    <STATE>MD</STATE>
                    <ZIP>20993</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
